Next-generation proteomics is enabling researchers to explore the proteome with unprecedented depth and scale. This article ...
Now available – completely unbiased, high throughput analysis of antibody binding to the complete mouse proteome with ...
Q4 2024 Earnings Call Transcript February 28, 2025 Operator: Good day, and thank you for standing by. Welcome to the Nautilus ...
The proteoCHIP LF 48 is a state-of-the-art label-free single-cell proteomics sample preparation solution. Designed for ...
Despite a delay in the platform launch, Nautilus Biotechnology Inc (NAUT) showcases advancements in proteomics and maintains a strong cash position.
SEATTLE, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today reported financial ...
BOSTON and SOUTH SAN FRANCISCO, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a clinical-stage precision medicine company seeking to unlock the proteome to advance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback